Ategra Capital Management’s AbbVie ABBV Stock Holding History

Ategra Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,987	Closed	-$1.27M	–	26
2024 Q1	$1.27M	Hold	6,987	–	–	0.57%	39
2023 Q4	$1.08M	Buy	6,987 +349	+5%	+$50.9K	0.48%	43
2023 Q3	$989K	Buy	6,638 +3,018	+83%	+$443K	0.54%	43
2023 Q2	$488K	Buy	3,620 +594	+20%	+$87.1K	0.26%	59
2023 Q1	$482K	Hold	3,026	–	–	0.26%	65
2022 Q4	$489K	Hold	3,026	–	–	0.25%	63
2022 Q3	$406K	Hold	3,026	–	–	0.21%	69
2022 Q2	$463K	Hold	3,026	–	–	0.24%	67
2022 Q1	$491K	Hold	3,026	–	–	0.22%	71
2021 Q4	$410K	Hold	3,026	–	–	0.18%	82
2021 Q3	$326K	Sell	3,026 -98	-3%	-$11.2K	0.16%	87
2021 Q2	$352K	Buy	3,124 +25	+0.8%	+$2.82K	0.17%	84
2021 Q1	$335K	Buy	3,099 +80	+3%	+$8.56K	0.19%	84
2020 Q4	$323K	Buy	3,019 +52	+2%	+$5K	0.23%	76
2020 Q3	$260K	Sell	2,967 -868	-23%	-$81.7K	0.23%	72
2020 Q2	$377K	Buy	3,835 +548	+17%	+$48.2K	0.36%	59
2020 Q1	$250K	Buy	3,287 +302	+10%	+$25.7K	0.29%	62
2019 Q4	$264K	Buy	2,985 +56	+2%	+$4.65K	0.22%	76
2019 Q3	$222K	Sell	2,929 -761	-21%	-$52.2K	0.2%	89
2019 Q2	$268K	Sell	3,690 -100	-3%	-$7.86K	0.25%	83
2019 Q1	$305K	Buy	+3,790	New	+$310K	0.3%	74

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ategra Capital Management's ABBV Position: Q2 2024 in Review

Ategra Capital Management sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 6,987 shares — an estimated $1.27M sold.

Ategra Capital Management first reported a position in ABBV in Q1 2019 and held it in 21 quarters. The position peaked at $1.27M in Q1 2024. 3,364 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

Ategra Capital Management reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
Ategra Capital Management sold 6,987 AbbVie shares in Q2 2024, an estimated $1.27M.
Ategra Capital Management first reported a position in AbbVie in Q1 2019 and held it in 21 quarters.
Ategra Capital Management's AbbVie position peaked at $1.27M in Q1 2024.
3,364 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Ategra Capital Management's 13F filing for Q2 2024, filed 14 Feb 2025.